Colgate-Palmolive Company (CL)
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at Colgate-Palmolive Company.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Appears in These Scanners
This stock currently matches 3 of our scanner strategies — each hit links to the scanner.
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners
Trading Day
Key levels of the most recently completed trading day — not a live quote.
52-Week Range
Current price 91.30 $ — 68% of the range above the low.
Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 08/03/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
Quality & Screener
AI Rating
–Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built
Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.
Analysts & Price Target
The price target sits 7.3% above the current price.
- Consensus
- Sell
- Analyst Ratings
- 22
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 3.87 | 3.84 – 3.94 | 21,409 | 4.8% | 11 |
| 12/31/2027 | 4.07 | 3.95 – 4.24 | 22,083 | 5.2% | 20 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Next Reporting Date
Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | 0.90 | 3.30 | 4,944 | -0.10 | 14.90 | 1,269 | 1,085 |
| 2025: Q1 | 0.84 | 1.40 | 4,911 | -3.00 | 14.10 | 600 | 476 |
| 2025: Q2 | 0.91 | 2.50 | 5,110 | 1.00 | 14.50 | 884 | 776 |
| 2025: Q3 | 0.91 | 1.20 | 5,131 | 1.90 | 14.30 | 1,261 | 1,106 |
| 2025: Q4 | -0.05 | -105.10 | 5,230 | 5.80 | -0.70 | 1,453 | 1,276 |
| 2026: Q1 | 0.80 | -4.40 | 5,324 | 8.40 | 12.10 | 747 | 609 |
| 2026: Q2 | 0.86 | -5.50 | 5,361 | 4.90 | 12.90 | 995 | 995 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Annual Figures
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2016 | 15,195 | 3,960 | 2,441 | 2.72 | 3,141 | 17 | 12,123 |
| 2017 | 15,454 | 4,009 | 2,024 | 2.28 | 3,054 | 243 | 12,676 |
| 2018 | 15,544 | 3,850 | 2,400 | 2.75 | 3,056 | 197 | 12,161 |
| 2019 | 15,693 | 3,762 | 2,367 | 2.75 | 3,133 | 558 | 15,034 |
| 2020 | 16,471 | 3,911 | 2,695 | 3.14 | 3,719 | 1,101 | 15,920 |
| 2021 | 17,421 | 3,886 | 2,166 | 2.55 | 3,325 | 971 | 15,040 |
| 2022 | 17,967 | 3,585 | 1,785 | 2.13 | 2,556 | 806 | 15,731 |
| 2023 | 19,457 | 4,131 | 2,300 | 2.77 | 3,745 | 957 | 16,393 |
| 2024 | 20,101 | 4,383 | 2,889 | 3.51 | 4,107 | 544 | 16,046 |
| 2025 | 20,382 | 4,348 | 2,132 | 2.63 | 4,198 | 365 | 16,330 |
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
About the Company
Colgate-Palmolive Company fertigt und verkauft mit ihren Tochtergesellschaften Konsumgüter in den USA und international. Sie ist in zwei Segmenten tätig: Oral, Personal and Home Care sowie Pet Nutrition.
| Employees | 33,600 |
|---|---|
| Headquarters | New York, NY |
| Address | 300 Park Avenue, 10022-7499 New York, United States |
| Phone | 212 310 2000 |
| Website | colgatepalmolive.com |
| IPO Date | 3. Jan 1977 |
| ISIN | US1941621039 |
| Stock Split | 2:1 on 05/16/2013 |
Management
| Name | Title | Birth Year |
|---|---|---|
| Noel R. Wallace | Chairman, CEO & President | 1964 |
| Stanley J. Sutula III | Chief Financial Officer | 1966 |
| Panagiotis Tsourapas | COO of Global Customer Dev., Europe Middle East Africa, Asia Pacific & Global Skin Health | 1965 |
| Shane Grant | Chief Operating Officer of Americas | 1975 |
| Stephan Habif | Chief Technology Officer | – |
| David Foster | Chief Information Officer | – |
| Claire L. Ross C.F.A. | Executive Vice President of Investor Relations | – |
| Betsy Fishbone | EVP, Chief Legal Officer & Secretary | – |
| Eutychus Karuru | Executive Vice President of Internal Audit & Compliance | – |
| Dana Bolden | Chief Communications Officer | 1968 |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Chart
Interactive price chart (TradingView).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.